feed,title,long_url,short_url
Benzinga,"Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of ""Risks Of Secondary Cancer'",https://benzinga.com/general/biotech/24/01/36760938/gileads-tecartus-dropped-from-fda-list-of-car-t-therapy-with-updated-label-warning-of-risks-of-se,https://da.gd/R1YZmD
